Kamp C, Petersen J, Faltermeier P, Juul S, Sillassen C, Siddiqui F
BMC Psychiatry. 2025; 25(1):67.
PMID: 39844067
PMC: 11755810.
DOI: 10.1186/s12888-024-06396-6.
Kamp C, Petersen J, Faltermeier P, Juul S, Siddiqui F, Moncrieff J
Epidemiol Psychiatr Sci. 2024; 33:e51.
PMID: 39440379
PMC: 11561525.
DOI: 10.1017/S2045796024000520.
Escrichs A, Sanz Perl Y, Fisher P, Martinez-Molina N, G-Guzman E, Frokjaer V
Mol Psychiatry. 2024; 30(3):1069-1079.
PMID: 39256549
PMC: 11835742.
DOI: 10.1038/s41380-024-02690-7.
Kamp C, Petersen J, Faltermeier P, Juul S, Siddiqui F, Barbateskovic M
BMJ Ment Health. 2024; 27(1.
PMID: 39093721
PMC: 10806869.
DOI: 10.1136/bmjment-2023-300730.
Turnier-Shea Y, Peterson G, Rybak M, Pridmore S
Brain Sci. 2024; 14(5).
PMID: 38790394
PMC: 11118001.
DOI: 10.3390/brainsci14050415.
Rationale and design of a double-blinded, randomized placebo-controlled trial of 40 Hz light neurostimulation therapy for depression (FELIX).
Sakalauskaite L, Hansen L, Dubois J, Larsen M, Feijoo G, Carstensen M
Ann Med. 2024; 56(1):2354852.
PMID: 38767238
PMC: 11107857.
DOI: 10.1080/07853890.2024.2354852.
Schema therapy versus treatment as usual for outpatients with difficult-to-treat depression: study protocol for a parallel group randomized clinical trial (DEPRE-ST).
Arendt I, Gondan M, Juul S, Hastrup L, Hjorthoj C, Bach B
Trials. 2024; 25(1):266.
PMID: 38627837
PMC: 11022394.
DOI: 10.1186/s13063-024-08079-9.
Chronotherapy for patients with a depressive episode treated in a public outpatient mental healthcare clinic in Norway: protocol for a randomised controlled trial.
Ramfjord L, Kahn N, Langsrud K, Halvorsen J, Morken G, Saksvik S
BMJ Open. 2024; 14(1):e076039.
PMID: 38171633
PMC: 10773329.
DOI: 10.1136/bmjopen-2023-076039.
The HAM-D6 through the lens of grief: Clinical considerations for administering the six-item Hamilton Depression Rating Scale in the context of bereavement.
Goldman M, Napolitano S, Roberts K, Lichtenthal W
Palliat Support Care. 2023; 21(6):1079-1084.
PMID: 37877263
PMC: 11110716.
DOI: 10.1017/S1478951523001487.
Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression-a NeuroPharm study.
Rasmussen A, Larsen S, Ozenne B, Kohler-Forsberg K, Stenbaek D, Jorgensen M
Transl Psychiatry. 2023; 13(1):247.
PMID: 37414758
PMC: 10325956.
DOI: 10.1038/s41398-023-02551-x.
Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants.
Yavorsky C, Ballard E, Opler M, Sedway J, Targum S, Lenderking W
Front Psychiatry. 2023; 14:1135828.
PMID: 37333908
PMC: 10272853.
DOI: 10.3389/fpsyt.2023.1135828.
Examination of Outcomes among Sexual Minorities in Treatment for Obsessive-Compulsive and Related Disorders.
Bezahler A, Kuckertz J, Schreck M, Narine K, Dattolico D, Falkenstein M
J Obsessive Compuls Relat Disord. 2023; 33.
PMID: 37220532
PMC: 10201929.
DOI: 10.1016/j.jocrd.2022.100724.
The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential....
Jorgensen C, Juul S, Siddiqui F, Horowitz M, Moncrieff J, Munkholm K
Syst Rev. 2023; 12(1):57.
PMID: 36991504
PMC: 10061867.
DOI: 10.1186/s13643-023-02221-5.
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale.
Fu C, Erus G, Fan Y, Antoniades M, Arnone D, Arnott S
BMC Psychiatry. 2023; 23(1):59.
PMID: 36690972
PMC: 9869598.
DOI: 10.1186/s12888-022-04509-7.
Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study.
Kohler-Forsberg K, Ozenne B, Larsen S, Poulsen A, Landman E, Dam V
Transl Psychiatry. 2022; 12(1):273.
PMID: 35821015
PMC: 9276803.
DOI: 10.1038/s41398-022-02034-5.
Edible Mushrooms as a Potential Component of Dietary Interventions for Major Depressive Disorder.
Fijalkowska A, Jedrejko K, Sulkowska-Ziaja K, Ziaja M, Kala K, Muszynska B
Foods. 2022; 11(10).
PMID: 35627059
PMC: 9141008.
DOI: 10.3390/foods11101489.
Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression.
Jorgensen A, Kohler-Forsberg K, Henriksen T, Weimann A, Brandslund I, Ellervik C
Transl Psychiatry. 2022; 12(1):204.
PMID: 35577781
PMC: 9110351.
DOI: 10.1038/s41398-022-01969-z.
Impact of chosen cutoff on response rate differences between selective serotonin reuptake inhibitors and placebo.
Lisinski A, Hieronymus F, Nilsson S, Eriksson E
Transl Psychiatry. 2022; 12(1):160.
PMID: 35422023
PMC: 9010419.
DOI: 10.1038/s41398-022-01882-5.
Validation of the Brazilian Portuguese version of the Quick Inventory of Depressive Symptomatology and Self-Report (QIDS-SR16) for the Brazilian population.
Bandinelli L, Schafer J, Kluwe-Schiavon B, Grassi-Oliveira R
Trends Psychiatry Psychother. 2022; 45:e20200378.
PMID: 35085434
PMC: 10241525.
DOI: 10.47626/2237-6089-2020-0378.
Neuroimmunological investigations of cerebrospinal fluid in patients with recent onset depression - a study protocol.
Sorensen N, Orlovska-Waast S, Jeppesen R, Christensen R, Benros M
BMC Psychiatry. 2022; 22(1):35.
PMID: 35022028
PMC: 8756720.
DOI: 10.1186/s12888-021-03633-0.